FMFilipa Magalhães

Filipa Magalhães

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Filipa Magalhães has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Spy and Zen Forest Exergames as Sources of Digital Biomarkers for Psoriatic Arthritis: A Co-Design Paradigm

    by Bárbara Ramalho, Samuel Gomes, Filipa Magalhães, Rodolfo Costa, Joana Matias, Marta Vicente, Pedro Abreu, Sandra Gama, Vasileios Charisis, Leontios J. Hadjileontiadis, et al.

    Psoriatic Arthritis (PsA) is a chronic rheumatic condition characterized by joint stiffness, reduced mobility, and persistent pain. Alongside pharmacological treatments, physio-therapy and structured exercise are commonly prescribed to improve range of motion and physical function. However, a prevalence of low consistency, high costs, and lack of engagement leads to high drop-out rates, making these interventions ineffective. Exergames, short for exercise games, provide an accessible alternative to complement traditional interventions, which embed therapeutic movements into game mechanics, motivating patients to remain active and consistent in their rehabilitation routines. This work presents the design of two PsA-focused exergames, The Spy and Zen Forest. Both were co-designed with 29 stakeholders, including PsA patients, clinicians, researchers, and technical experts, ensuring that they align with clinical goals, address patient needs, and support safe and effective physical engagement. In The Spy, players act as undercover agents and complete a sequence of physically engaging missions, designed to stimulate dynamic body movement that boost coordination and enhance mobility, balance, strength, and flexibility. In Zen Forest, players perform slow and calm stretching routines inspired by Pilates and yoga exercises, improving their flexibility, relaxation, and body awareness. Beyond therapeutic engagement, the proposed exergames integrate multimodal sensing capabilities that enable the extraction of candidate digital biomarkers. These candidate biomarkers may support objective monitoring of patient performance and inform future personalized rehabilitation strategies for PsA, ultimately leading to better disease management and improved patient quality of life.

  • Open Access

    Co-Designing Mobile Serious Games to Support Patients With Psoriatic Arthritis and Chronic Pain: Mixed Methods Study

    by Bárbara Ramalho, Samuel Gomes, Marta Silva Vicente, Filipa Magalhães, Rodolfo Gonçalves Costa, Sandra Gama, Vasileios Charisis, Leontios Hadjileontiadis, Sofia B Dias, iPROLEPSIS Consortium

    Background: Serious games offer promising avenues for clinical care by enhancing patient engagement and delivering therapeutic benefits. In psoriatic arthritis (PsA), chronic pain contributes to emotional distress, functional limitations, and reduced well-being. While symptom-tracking apps exist, few digital interventions directly address chronic pain through engaging, therapeutic experiences tailored to patients’ cognitive and physical needs. Objective: This study aimed to co-design mobile serious games — NoPain Games—to support patients with PsA in managing chronic pain. Conducted within the iPROLEPSIS Horizon Europe project, the study involved a multidisciplinary cocreation session with rheumatologists, researchers, and technical experts, followed by a usability feedback session with patients with PsA. The goal was to identify therapeutic priorities, refine game mechanics, and assess usability to inform the development of personalized, accessible digital interventions. Methods: A sequential mixed methods design was used. First, a 90-minute remote cocreation session was held with 14 experts (6 rheumatologists, 4 technical experts, and 4 researchers) from 3 European countries. Participants reviewed game storyboards and discussed therapeutic and design priorities. Thematic analysis of transcribed discussions identified key insights. Next, a 60-minute remote usability feedback session was conducted with 5 patients with PsA (aged 25‐64 y), who interacted with 2 high-fidelity game prototypes (Space Oddity and Four Seasons). Usability was assessed using the System Usability Scale (SUS), and qualitative feedback was collected through moderated discussion. Item-level analysis using item characteristic curves provided deeper insight into usability perceptions and item sensitivity. All ethics requirements were met for both study phases. Results: Thematic analysis of the transcribed dialogs of the cocreation session revealed three core themes: (1) therapeutic benefits (pain distraction, memory enhancement, cognitive stimulation, stress reduction, and creative engagement); (2) game difficulty (balancing duration and complexity to sustain engagement without fatigue); and (3) accessibility and interaction (addressing physical limitations, optimizing touchscreen usability, and ensuring inclusive design). These insights informed the development of 2 NoPain Game prototypes, which received a SUS score of 79 (SD 10.4; 95% CI 69.89‐88.11), indicating good usability. Item characteristic curve analysis showed strong discrimination for learnability, while ease of use and confidence exhibited ceiling effects. Items like support needs and inconsistency showed minimal variability, and the learning curve demonstrated delayed but meaningful responsiveness at higher usability levels. Qualitative feedback reinforced the relevance of difficulty adjustment, technical refinements, and game mechanics, offering actionable insights for future iterations and broader implementation. Conclusions: This study uniquely contributes to the field by co-designing mobile serious games specifically for patients with PsA, integrating expert and patient input to address chronic pain through accessible, cognitively engaging digital interventions—an approach not previously explored in this population. Future work will refine game mechanics, integrate adaptive difficulty, and conduct clinical trials to evaluate therapeutic efficacy. NoPain Games may serve as complementary tools within digital care ecosystems, offering support tailored to the therapeutic needs and physical limitations of patients with PsA underserved by conventional therapies.


  • Open Access

    Dynamic Difficulty Adjustment in Psoriatic Arthritis Serious Games Using Learning-Driven Policies

    by Samuel Gomes, Barbara Ramalho, Joao Caldeira, Filipa Magalhaes, Marta Vicente, Sandra Gama, Maria Mytilinaiou, Theodoros Dimitroulas, Vasileios Charisis, Stelios Hadjidimitriou, et al.